Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
Publishing timestamp: 2024-06-06 12:18:40
Summary
Anat Ashkenazi, the incoming CFO of Alphabet, has experience running books at Eli Lilly during a period of historic growth. Eli Lilly has become the most valuable drugmaker in the world due to the success of weight loss drugs. Ashkenazi will be entering Alphabet at a time of big changes, with the company focusing on investments in generative artificial intelligence.
Sentiment: NEUTRAL
Keywords: pharmaceuticals, google, breaking news: technology, sergey brin, internet, sundar pichai, business news, technology, morgan stanley, alphabet inc, eli lilly and co,